Semaglutide trials (STEP 1-4) demonstrated 15-22% weight loss over 68 weeks, while tirzepatide (SURMOUNT trials) showed 20-24% weight loss at the highest doses
Richardson SH, Wong G, Garner E, Izzy M, Srivastava G
Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH
The Easiest GLP-1 Diet Meal Plan Cookbook for Beginners: Crave-Crushing Recipes to Maximize GLP-1 Weight Loss, Boost Energy, and Keep Results Locked In [Monroe, Lila] on Amazon.com
Where GLP BodyGuard's published positioning differs is its emphasis on body-composition habit tracking rather than medication management
Its presence on her list means she is receiving incretin-mimetic therapy in addition to her metformin, addressing her hyperglycemia through a second mechanism: slowing gastric emptying, stimulating insulin release in a glucose-dependent manner, and inhibiting glucagon
